Neurodegeneration最新文献

{"title":"Cognitive deficits precede motor deficits in a slowly progressing model of parkinsonism in the monkey","authors":"J.S Schneider,&nbsp;A Pope-Coleman","doi":"10.1016/1055-8330(95)90014-4","DOIUrl":"10.1016/1055-8330(95)90014-4","url":null,"abstract":"<div><p>Five adult <em>Macaca fascicularis</em> monkeys were trained to perform tests of cognitive and motor functioning that included a complex visual pattern discrimination task, an object retrieval task, a test of task persistence, and a timed motor task. Once stable baseline performance was achieved, monkeys were administered 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) at doses of 0.05 to 0.075 mg/kg, 2 to 3 times per week for a total of 24 weeks. Animals were assessed weekly for performance on the previously learned tasks. All monkeys developed performance deficits in a predictable pattern with behavioural and cognitive deficits (i.e. deficits in task persistence and the cognitive component of object retrieval) appearing in advance of measurable motor deficits. Deficits in visual pattern discrimination never appeared. These results show that specific cognitive dysfunction pre-dates motor dysfunction in a chronic, slowly progressing parkinson model in monkeys and support the contention that cognitive deficits in Parkinson's disease may precede the motor signs of the disorder and may not be caused by them.</p></div>","PeriodicalId":19127,"journal":{"name":"Neurodegeneration","volume":"4 3","pages":"Pages 245-255"},"PeriodicalIF":0.0,"publicationDate":"1995-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/1055-8330(95)90014-4","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19561159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A functional role for corpora amylacea based on evidence from complement studies","authors":"S.K Singhrao ,&nbsp;B.P Morgan ,&nbsp;J.W Neal ,&nbsp;G.R Newman","doi":"10.1016/1055-8330(95)90024-1","DOIUrl":"10.1016/1055-8330(95)90024-1","url":null,"abstract":"<div><p>Few theories have been advanced for the production of corpora amylacea (CA) by the normal ageing brain and by the CNS under various neurological conditions. Proteins derived from neurons and oligodendrocytes are found in CA and to understand their origins brain tissue from patients with Alzheimer's disease (AD), multiple sclerosis (MS) and Pick's disease (PD) were tested for complement activity. All CA were immunopositive for antisera to classical pathway-specific components, the activation products C3d and the terminal complement complex (TCC), the C3 convertase regulator membrane cofactor protein (MCP) and the fluid phase regulators S-protein and clusterin. CA were immunonegative for the alternative complement pathway proteins and the complement regulators, decay accelerating factor (DAF) and CD59. Western immunoblotting of isolated solubilized CA from the same tissues demonstrated a week band for MCP but TCC was more easily shown by immunoprecipitaton. A filamentous fringe around CA, probably of astrocytic origin, was also immunopositive for complement factors. CA consist of an inert mucopolysaccharide matrix encasing ubiquitinated proteins, resulting from death of and damage to neurons, myelin and oligodendrocytes. A function of CA, therefore, could be to prevent the recognition of these immunogenic proteins by lymphocytes and microglia and thus protect the CNS from further injury.</p></div>","PeriodicalId":19127,"journal":{"name":"Neurodegeneration","volume":"4 3","pages":"Pages 335-345"},"PeriodicalIF":0.0,"publicationDate":"1995-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/1055-8330(95)90024-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19561605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Neuroprotection against NMDA induced cell death in rat nucleus basalis by Ca2+ antagonist nimodipine, influence of aging and developmental drug treatment","authors":"P.G.M Luiten ,&nbsp;B.R.K Douma ,&nbsp;E.A Van der Zee ,&nbsp;C Nyakas","doi":"10.1016/1055-8330(95)90020-9","DOIUrl":"10.1016/1055-8330(95)90020-9","url":null,"abstract":"<div><p>In the current study the neuroprotective effect of the L-type calcium channel antagonist nimodipine in rat brain was investigated in N-methyl-D-aspartate-induced neuronal degeneration in vivo. In the present model NMDA was unilaterally injected in the magnocellular nucleus basalis and the neurotoxic impact assessed by measuring cortical cholinergic fibre loss as a percentage of fibre density of the intact control hemisphere. This procedure proved to be a reproducible model in which the degree of damage was almost linearly proportional to the NMDA dose. Neuroprotection by nimodipine was determined in a number of conditions. First, the effect of nimodipine treatment in adult animals starting two weeks prior to neurotoxic injury was compared with neuroprotection provided by perinatal treatment of the mother animals with the calcium antagonist. Surprisingly, the degree of protection was in both cases similar, yielding almost 30% reduction of fibre loss. The neuroprotective effect in adulthood of perinatal nimodipine treatment may be explained by developmentally enhanced calcium binding proteins or persistent developmental changes in calcium channel characteristics. Protection by nimodipine was also investigated in aged, 26 month old rats. Compared to young adult cases, aged animals proved to be less vulnerable to NMDA exposure, while nimodipine application was more potent, thus yielding a reduction of nearly 50% in nerve fibre damage induced by NMDA infusions. Possible mechanisms of differential calcium influx in the various experimental conditions will be discussed.</p></div>","PeriodicalId":19127,"journal":{"name":"Neurodegeneration","volume":"4 3","pages":"Pages 307-314"},"PeriodicalIF":0.0,"publicationDate":"1995-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/1055-8330(95)90020-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19561665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Origins and evolution of huntington disease chromosomes","authors":"S.E Andrew ,&nbsp;M.R Hayden","doi":"10.1016/1055-8330(95)90013-6","DOIUrl":"10.1016/1055-8330(95)90013-6","url":null,"abstract":"<div><p>Huntington disease (HD) is one of five neurodegenerative disorders resulting from an expansion of a CAG repeat located within the coding portion of a novel gene. CAG repeat expansion beyond a particular repeat size has been shown to be a specific and sensitive marker for the disease. A strong inverse correlation is evident between CAG length and age of onset. Sporadic cases of HD have been shown to arise from intermediate sized alleles in the unaffected parent. The biochemical pathways underlying the relationship between CAG repeat length and specific cell death are not yet known. However, there is an increasing understanding of how and why specific chromosomes and not others expand into the disease range. Haplotype analysis has demonstrated that certain normal chromosomes, with CAG lengths at the high range of normal, are prone to further expansion and eventually result in HD chromosomes. New mutations preferentially occur on normal chromosomes with these same haplotypes associated with higher CAG lengths. The distribution of different haplotypes on control chromosomes in different populations is thus one indication of the frequency of new mutations for HD within that population. Analysis of normal chromosomes in different populations suggests that genetic factors contribute to expansion and account for the variation in prevalence rates for HD worldwide.</p></div>","PeriodicalId":19127,"journal":{"name":"Neurodegeneration","volume":"4 3","pages":"Pages 239-244"},"PeriodicalIF":0.0,"publicationDate":"1995-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/1055-8330(95)90013-6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19561157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","authors":"Vernice Jackson-Lewis,&nbsp;Michael Jakowec,&nbsp;Robert E Burke,&nbsp;Serge Przedborski","doi":"10.1016/1055-8330(95)90015-2","DOIUrl":"10.1016/1055-8330(95)90015-2","url":null,"abstract":"<div><p>Mechanisms responsible for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopamine (DA) neuronal death remain unknown and in mice it is even unclear whether neuronal death does occur. <em>In vitro</em> studies suggest that 1-methyl-4-phenylpyridinium ion (MPP⁺), the active metabolite of MPTP, kills neurons by apoptosis. Herein, we investigated whether MPTP induces DA neuronal death <em>in vivo</em> in mice and whether the mechanism is that of apoptosis. C57/bl Mice received different doses of MPTP administered in four intraperitoneal injections every 2 hours and were sacrificed at different time points for analyses of tyrosine hydroxylase (TH) immunohistochemistry, silver staining, and Nissl staining within the mesencephalon. We found that MPTP induces neuronal destruction in the substantia nigra pars compacta (SNpc) and the ventral tegmental area (VTA). The active phase of degeneration began at 12 h postinjection and continued up to 4 days. During this period, there was a greater decrease in TH-defined neurons than in Nissl-stained neurons suggesting that MPTP can cause a loss in TH without necessarily destroying the neuron. Thereafter, neuronal counts by both techniques equalized and there was no further loss of DA neurons. Dying neurons showed shrunken eosinophilic cytoplasm and shrunken darkly stained nuclei. Double staining revealed degenerating neurons solely among TH positive neurons of SNpc and VTA. At no time point and at no dose of MPTP was apoptosis observed. In addition, <em>in situ</em> labelling revealed no evidence of DNA fragmentation. This study demonstrates that the MPTP mouse model replicates several key features of neurodegeneration of DA neurons in PD and provides no <em>in vivo</em> evidence that, using this specific paradigm of injection, MPTP kills DA neurons by apoptosis.</p></div>","PeriodicalId":19127,"journal":{"name":"Neurodegeneration","volume":"4 3","pages":"Pages 257-269"},"PeriodicalIF":0.0,"publicationDate":"1995-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/1055-8330(95)90015-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19561162","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"An endogenous dopaminergic neurotoxin: Implication for Parkinson's disease","authors":"Michael B Mattammal ,&nbsp;John H Haring ,&nbsp;Haung D Chung ,&nbsp;Girija Raghu ,&nbsp;Randy Strong","doi":"10.1016/1055-8330(95)90016-0","DOIUrl":"10.1016/1055-8330(95)90016-0","url":null,"abstract":"<div><p>Oxidation of dopamine by monoamine oxidase results in the endogenous metabolite 3,4-dihydroxyphenylacetaldehyde (DOPAL). The toxicity of DOPAL for dopaminergic neurons was investigated using rat neostriatal synaptosomes, PC-12 cells and cultures of fetal rat dissociated mesencephalon. The Na⁺-dependent uptake of [³H]DOPAL in synaptosomes was inhibited by mazindol. DOPAL selectively inhibited dopamine uptake but not [¹⁴C]GABA uptake, induced membrane damage and liberation of dopamine into the medium. Incubation of PC-12 cells with 6.5 μM of DOPAL for 24 h caused degeneration of the neuritic process, and the number of viable cells were reduced by 25% of control. There were practically no surviving cells after 24 h of incubation with 33 μM of DOPAL. After 8 h of treatment with 33 μM of DOPAL, dopamine and 3,4-dihydroxyphenylacetic acid content in the cells were reduced by 38% and 53% of control. DOPAL-induced cell damage released lactic acid dehydrogenase into the incubation media. This toxic effect of DOPAL was time- and concentration-dependent. In mesencephalic cultures, after exposure to 33 μM of DOPAL, the surviving TH⁺ cells showed rounded cell body, and fibre network was highly reduced. These results indicate DOPAL is a neurotoxin and may be involved in the degeneration of dopaminergic neurons.</p></div>","PeriodicalId":19127,"journal":{"name":"Neurodegeneration","volume":"4 3","pages":"Pages 271-281"},"PeriodicalIF":0.0,"publicationDate":"1995-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/1055-8330(95)90016-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19561660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Quantification of βAPP immunoreactive pre-α cells in the entorhinal cortex using image analysis","authors":"Jeanette E McKenzie ,&nbsp;Stephen M Gentleman ,&nbsp;Gareth W Roberts ,&nbsp;David I Graham ,&nbsp;M Claire Royston","doi":"10.1016/1055-8330(95)90019-5","DOIUrl":"10.1016/1055-8330(95)90019-5","url":null,"abstract":"<div><p>The neuropathological diagnosis of Alzheimer's disease requires an assessment of the quantity of pathology present. Advances in molecular biology have highlighted the role of β-amyloid precursor protein (βAPP) in the pathogenesis of the disease. This protein is found in neurons and other cells and many neuropathological studies would benefit from a method which generates reliable data on the numbers of cells containing significant amounts of the protein. Classically, generation of such data would have involved laborious manual counting. This particular approach carries low levels of inter- and intra-rater reliability and is much dependent on the skill and experience of the operator. We have used immunocytochemistry to specifically define a single cell population, pre-α cells, containing βAPP, and have developed a computerized cell counting programme that can reliably quantify these cells in human post-mortem brain samples. We have obtained a high level of accuracy (&gt;95%) and efficiency in identifying and quantifying target cells and have demonstrated that our protocol can be used effectively by both novice and expert. This method could be easily configured to provide quantitative data for a wide range of immunocytochemically defined cell populations.</p></div>","PeriodicalId":19127,"journal":{"name":"Neurodegeneration","volume":"4 3","pages":"Pages 299-306"},"PeriodicalIF":0.0,"publicationDate":"1995-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/1055-8330(95)90019-5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19561664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Death of cultured human neuroblastoma cells induced by HIV-1 gp120 is prevented by NMDA receptor antagonists and inhibitors of nitric oxide and cyclooxygenase","authors":"M.T Corasaniti ,&nbsp;G Melino ,&nbsp;M Navarra ,&nbsp;E Garaci ,&nbsp;A Finazzi-Agrò ,&nbsp;G Nistico","doi":"10.1016/1055-8330(95)90021-7","DOIUrl":"10.1016/1055-8330(95)90021-7","url":null,"abstract":"<div><p>The cytotoxic effects of the human immunodeficiency virus type 1 (HIV-1) coat protein gp120 were studied in human CHP100 neuroblastoma cell cultures. Incubation of neuroblastoma cultures with gp120 (1 pM-10 nM) induces cell death which is not concentration-related. The significant cell death evoked by 10 pM gp120 was prevented by neutralization of the viral protein with a monoclonal anti-gp120 (IgG) antibody. In addition, gp120-induced cytotoxicity was inhibited by [DL-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid] (CGP37849; 100 μM), [(±)-3R∗, 4as∗, 6R∗, 8aR∗-6-(phosphonomethyl) decahydro-isoquinoline-3-carboxylic acid] (LY274614; 100 μM), MK801 (dizocilpine; 200 nM) and 7-chloro kynurenic acid (100 μM), selective antagonists of the NMDA receptor complex; by contrast, (6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; 100 μM), a non-NMDA antagonist, was ineffective. Prevention of the lethality elicited by the HIV-1 coat protein was also obtained by incubating neuroblastoma cells with gp120 in Ca²⁺-free medium. The lethal effects induced by gp120 involve activation of L-arginine-nitric oxide (NO) pathway since these were prevented by haemoglobin (10 μM), a NO-trapping agent, and by D-arginine (1 mM), the less active enantiomer of the endogenous precursor of NO synthesis. Cytoprotection was also afforded by <em>N</em>^ω-nitro-L-arginine methyl ester (L-NAME; 200 μM), an inhibitor of NO synthase, and this was reversed by L-arginine (1 mM). Interestingly, indomethacin and flufenamic acid (10 μM), two inhibitors of cyclooxygenase, protected neuroblastoma cells from death induced by gp120. Furthermore, indomethacin prevented the neuroblastoma cell death evoked by exposure of cultures to sodium nitroprusside (SNP; 0.2–1.6 mM), a NO donor. Finally significant cytotoxic effects were observed after incubation of neuroblastoma cells with prostaglandin E₂ (0.1–10 μM). In conclusion, the present data suggest that death of human CHP100 neuroblastoma cells in culture produced by gp120 involves NO and PGE₂ production.</p></div>","PeriodicalId":19127,"journal":{"name":"Neurodegeneration","volume":"4 3","pages":"Pages 315-321"},"PeriodicalIF":0.0,"publicationDate":"1995-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/1055-8330(95)90021-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19561666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The neuroprotective effect of chlormethiazole on ischaemic neuronal damage following permanent middle cerebral artery ischaemia in the rat","authors":"Simon G Sydserff,&nbsp;Alan J Cross,&nbsp;A.Richard Green","doi":"10.1016/1055-8330(95)90022-5","DOIUrl":"10.1016/1055-8330(95)90022-5","url":null,"abstract":"<div><p>The ability of chloremethiazole to protect against ischaemic cell damage in a rat model of permanent focal ischaemia has been examined. Chlormethiazole (1 mmol/kg) was administered intraperitoneally either 1 or 3 h after occlusion of the middle cerebral artery with an intraluminal filament. Twenty four hours after the start of occlusion there was histological evidence for ischaemic damage in both cortex and striatum. The volume of ischaemic damage in control (saline injected) animals was 310 ± 25 mm³ (mean ± SEM; <em>n</em> = 6). Chlormethiazole administered 1 h after occlusion reduced this damage by 58% (128 ± 40 mm³; <em>n</em> = 6; <em>P</em> &lt; 0.01), protection being observed in both brain regions. The drug was ineffective when given 3 h after occlusion (304 ± 25 mm³; <em>n</em> = 5). Chlormethiazole had no effect on body temperature, mean arterial blood pressure, blood pH, pO₂ or pCO₂, but did induce mild bradycardia. Chlormethiazole therefore appears to be an effective neuroprotective agent in this model of permanent ischaemia, complementing previous data on the efficacy of this drug in other focal and global models of cerebral ischaemia.</p></div>","PeriodicalId":19127,"journal":{"name":"Neurodegeneration","volume":"4 3","pages":"Pages 323-328"},"PeriodicalIF":0.0,"publicationDate":"1995-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/1055-8330(95)90022-5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19561667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Manganese-induced reactive oxygen species: Comparison between Mn+2 and Mn+3","authors":"Syed F Ali ,&nbsp;Helen M Duhart ,&nbsp;Glenn D Newport ,&nbsp;George W Lipe ,&nbsp;William Slikker Jr.","doi":"10.1016/1055-8330(95)90023-3","DOIUrl":"10.1016/1055-8330(95)90023-3","url":null,"abstract":"<div><p>Manganese (Mn) is an essential element, the deficiency or excess of which is known to cause neurotoxicity in experimental animals and man. The mechanism of action of Mn neurotoxicity is still unclear. The present study was designed to evaluate whether <em>in vitro</em> or <em>in vivo</em> exposure to Mn produced reactive oxygen species (ROS). We also sought to determine if a single injection of Mn produces changes in monoamines concentration in different regions of rat brain. Adult Sprague-Dawley rats were dosed with 0, 50 or 100 mg/kg, ip with either MnCl₂ (Mn⁺²) or MnOAc (Mn⁺³) and were sacrificed 1 h after the dose was administered. Brains were quickly removed and dissected for neurochemical analysis. ROS were measured by a molecular probe, 2′,7′-dichlorofluorescein diacetate (DCFH-DA), and monoamines and their metabolites were measured by HPLC/EC. <em>In vitro</em> exposure to MnCl₂ (1–1000 μM) produced dose-dependent increases of ROS in striatum whereas MnOAc produced similar increases at much lower concentrations (1–100 μM). <em>In vivo</em> exposure to MnOAc (Mn⁺³) produced significant increases of ROS in caudate nucleus and hippocampus, whereas MnCl₂ (Mn⁺²) produced significant effects only in hippocampus. Concentrations of dopamine, serotonin and their metabolites (DOPAC, HVA and 5-HIAA) were not altered with acute injections of either MnCl₂ or MnOAc. These data suggest that both divalent and trivalent manganese induce ROS, however, Mn⁺³ is an order of magnitude more potent than Mn⁺².</p></div>","PeriodicalId":19127,"journal":{"name":"Neurodegeneration","volume":"4 3","pages":"Pages 329-334"},"PeriodicalIF":0.0,"publicationDate":"1995-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/1055-8330(95)90023-3","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19561668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}